根据条款,Harmony (HRMY)预计将以每股1.1059美元或6000万美元的现金收购Zynerba所有已发行股票。
根据某些临床、监管和销售里...查看全文
SeekingBiotech2023-08-14 21:36
$Harmony(HRMY)$ 收购$Zynerba制药(ZYNE)$
HRMY announced a definitive agreement to acquire Zynerba Pharmaceuticals for $1.1059 per share in cash, or $60 million, plus one non-tradeable contingent value right (CVR) per share, to receive potential additional payments of up t...查看全文
产业链观察2023-08-14 20:20
#药闻简讯# 2023年8月14日 -- 致力于为罕见神经疾病患者开发和商业化创新疗法的制药公司$Harmony(HRMY)$ 与$Zynerba制药(ZYNE)$ 达成的最终收购协议。
Zynerba 是针对包括脆性 X 综合征 (Fragile X syndrome, FXS) 在内的孤儿神经精神疾病开发创新透皮大麻素疗法的领先制药企业。
Zynerba ...查看全文
牛唐2021-02-07 16:49
$爵士制药(JAZZ)$ 收购了$吉瓦制药(GWPH)$ ,其他大麻制药概念股$Corbus制药控股(CRBP)$ 、$Zynerba制药(ZYNE)、$Cara Therapeutics(CARA)查看全文
牛唐2021-02-04 17:36
医药板块速评(2021.02.03)
1、AD药物继续疯狂,还有哪些AD概念股值得入手?$Cassava Sciences(SAVA)$
2、大麻药物概念股起飞,还有哪些相关概念股值得买入?$Zynerba制药(ZYNE)$
3、Reddit和WSB杀入医药板块,哪些概念股闻风而动?$SELLAS生命科学(SLS)$查看全文
chuminhua2020-07-02 21:32
6/30,Zynerba$Zynerba制药(ZYNE)$ 在宣布CBD(大麻素)凝胶在研药物Zygel用于罕见病脆性X综合征一项关键性III期研究 CONNECT-FX未达到主要终点和3个次要终点后,股价暴跌51%。这是这些年来该公司的CBD药物第4次在临床研究中失败。查看全文
Replix锐璞美股2020-04-08 16:56
$Zynerba制药(ZYNE)$ 小锐看了一下我们这段覆盖的药股,发现有一个共同的特征:管理层不!靠!谱!,比如我们覆盖的$Immunomedics(IMMU)$ $Avadel制药(AVDL)$ 还有Abeona Therapeutics。这些管理层全是坑爹货!说到ZYNE这家公司曾经因为大麻热而成为大热股票,但现在新鲜劲一过也被市场无情...查看全文
$Zynerba制药(ZYNE)$ 8-K Current report, items 8.01 and 9.01 Accession Number: 0001104659-20-003213 Act: 34 Size: 13 MB 网页链接
$Zynerba制药(ZYNE)$ SC 13G/A [Amend] Statement of acquisition of beneficial ownership by individuals Accession Number: 0001213900-19-025094 Act: 34 Size: 56 KB 网页链接
$Zynerba制药(ZYNE)$ 8-K - Current report Filed: 2019-11-06 AccNo: 0001104659-19-060256 Size: 180 KBItem 2.02: Results of Operations and Financial ConditionItem 9.01: Financial Statements and Exhibits 网页链接
$Zynerba制药(ZYNE)$ 10-Q - Quarterly report [Sections 13 or 15(d)] Filed: 2019-11-06 AccNo: 0001558370-19-010074 Size: 5 MB 网页链接
$Zynerba制药(ZYNE)$ 8-K - Current report Filed: 2019-09-24 AccNo: 0001104659-19-051099 Size: 4 MBItem 8.01: Other EventsItem 9.01: Financial Statements and Exhibits 网页链接
$Zynerba制药(ZYNE)$ 8-K - Current report Filed: 2019-09-18 AccNo: 0001104659-19-050481 Size: 84 KBItem 8.01: Other EventsItem 9.01: Financial Statements and Exhibits 网页链接
$Zynerba制药(ZYNE)$ 8-K - Current report Filed: 2019-08-30 AccNo: 0001104659-19-048256 Size: 476 KBItem 1.01: Entry into a Material Definitive AgreementItem 5.02: Departure of Directors or Certain Officers; Election of Directors; Appointment of Certain Officers: Compensatory ...
$Zynerba制药(ZYNE)$ 424B5 - Prospectus [Rule 424(b)(5)] Filed: 2019-08-30 AccNo: 0001104659-19-048268 Size: 483 KB 网页链接
$Zynerba制药(ZYNE)$ EFFECT - Notice of Effectiveness Filed: 2019-08-13 AccNo: 9999999995-19-001874 Size: 1 KB 网页链接
$Zynerba制药(ZYNE)$ 8-K - Current report Filed: 2019-08-06 AccNo: 0001104659-19-044130 Size: 4 MBItem 2.02: Results of Operations and Financial ConditionItem 8.01: Other EventsItem 9.01: Financial Statements and Exhibits 网页链接